Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Can a one-item mood scale do the trick? Predicting relapse over 5.5-years in recurrent depression.

van Rijsbergen GD, Bockting CL, Berking M, Koeter MW, Schene AH.

PLoS One. 2012;7(10):e46796. doi: 10.1371/journal.pone.0046796. Epub 2012 Oct 3.

2.

How do you feel? Detection of recurrent Major Depressive Disorder using a single-item screening tool.

van Rijsbergen GD, Burger H, Hollon SD, Elgersma HJ, Kok GD, Dekker J, de Jong PJ, Bockting CL.

Psychiatry Res. 2014 Dec 15;220(1-2):287-93. doi: 10.1016/j.psychres.2014.06.052. Epub 2014 Jul 10.

PMID:
25070177
3.

Understanding emotion and emotional scarring in recurrent depression.

van Rijsbergen GD, Hollon SD, Elgersma HJ, Kok GD, Dekker J, Schene AH, Bockting CL.

Compr Psychiatry. 2015 May;59:54-61. doi: 10.1016/j.comppsych.2015.02.010. Epub 2015 Feb 20.

PMID:
25749480
4.

The role of affect in predicting depressive symptomatology in remitted recurrently depressed patients.

de Jonge M, Dekker JJ, Kikkert MJ, Peen J, van Rijsbergen GD, Bockting CL.

J Affect Disord. 2017 Mar 1;210:66-71. doi: 10.1016/j.jad.2016.12.015. Epub 2016 Dec 18.

PMID:
28013124
5.

Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

Segal ZV, Kennedy S, Gemar M, Hood K, Pedersen R, Buis T.

Arch Gen Psychiatry. 2006 Jul;63(7):749-55.

PMID:
16818864
6.

The clinical effectiveness and cost of repetitive transcranial magnetic stimulation versus electroconvulsive therapy in severe depression: a multicentre pragmatic randomised controlled trial and economic analysis.

McLoughlin DM, Mogg A, Eranti S, Pluck G, Purvis R, Edwards D, Landau S, Brown R, Rabe-Heskith S, Howard R, Philpot M, Rothwell J, Romeo R, Knapp M.

Health Technol Assess. 2007 Jul;11(24):1-54.

7.

Novel Augmentation Strategies in Major Depression.

Martiny K.

Dan Med J. 2017 Apr;64(4). pii: B5338. Review.

PMID:
28385173
8.

Sensitivity to change of two depression rating scales for stroke patients.

Benaim C, Decavel P, Bentabet M, Froger J, Pélissier J, Pérennou D.

Clin Rehabil. 2010 Mar;24(3):251-7. doi: 10.1177/0269215509346087. Epub 2010 Jan 22.

PMID:
20097722
9.

Prediction of recurrence in recurrent depression: a 5.5-year prospective study.

ten Doesschate MC, Bockting CL, Koeter MW, Schene AH; DELTA Study Group.

J Clin Psychiatry. 2010 Aug;71(8):984-91. doi: 10.4088/JCP.08m04858blu.

PMID:
20797379
10.

Mood reactivity rather than cognitive reactivity is predictive of depressive relapse: a randomized study with 5.5-year follow-up.

van Rijsbergen GD, Bockting CL, Burger H, Spinhoven P, Koeter MW, Ruhé HG, Hollon SD, Schene AH.

J Consult Clin Psychol. 2013 Jun;81(3):508-17. doi: 10.1037/a0032223. Epub 2013 Mar 11.

PMID:
23477478
11.

Sertraline as monotherapy in the treatment of psychotic and nonpsychotic depression.

Simpson GM, El Sheshai A, Rady A, Kingsbury SJ, Fayek M.

J Clin Psychiatry. 2003 Aug;64(8):959-65.

PMID:
12927014
12.

Evaluating response to mood stabilizers in patients with mixed depression: A study of agreement between three different mania rating scales and a depression rating scale.

Shansis FM, Reche M, Capp E.

J Affect Disord. 2016 Jun;197:1-7. doi: 10.1016/j.jad.2016.02.064. Epub 2016 Mar 3.

PMID:
26950019
13.

Validation of screening measures for assessing mood in stroke patients.

Bennett HE, Thomas SA, Austen R, Morris AM, Lincoln NB.

Br J Clin Psychol. 2006 Sep;45(Pt 3):367-76. Erratum in: Br J Clin Psychol. 2007 Jun;46(Pt 2):following 251.

PMID:
17147102
14.

Venlafaxine versus lithium monotherapy of rapid and non-rapid cycling patients with bipolar II major depressive episode: a randomized, parallel group, open-label trial.

Amsterdam JD, Wang CH, Shwarz M, Shults J.

J Affect Disord. 2009 Jan;112(1-3):219-30. doi: 10.1016/j.jad.2008.03.029. Epub 2008 May 16.

PMID:
18486235
15.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
16.

A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression.

Eranti S, Mogg A, Pluck G, Landau S, Purvis R, Brown RG, Howard R, Knapp M, Philpot M, Rabe-Hesketh S, Romeo R, Rothwell J, Edwards D, McLoughlin DM.

Am J Psychiatry. 2007 Jan;164(1):73-81.

PMID:
17202547
17.

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:86-91. doi: 10.1016/j.pnpbp.2013.09.016. Epub 2013 Oct 2.

PMID:
24096053
18.

Fluoxetine treatment of depressed patients with comorbid anxiety disorders.

Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.

J Psychopharmacol. 2002 Sep;16(3):215-9.

PMID:
12236627
19.

Assessment of mood in aphasia following stroke: validation of the Dynamic Visual Analogue Mood Scales (D-VAMS).

Barrows PD, Thomas SA.

Clin Rehabil. 2018 Jan;32(1):94-102. doi: 10.1177/0269215517714590. Epub 2017 Jun 27.

PMID:
28653547
20.

Mood-linked responses in medial prefrontal cortex predict relapse in patients with recurrent unipolar depression.

Farb NA, Anderson AK, Bloch RT, Segal ZV.

Biol Psychiatry. 2011 Aug 15;70(4):366-72. doi: 10.1016/j.biopsych.2011.03.009. Epub 2011 Apr 30.

Supplemental Content

Support Center